Aileen Gibbons is the Managing Director at H.C. Wainwright & Co., LLC, based in the United States. She has been with the firm since November 2016, initially serving as Director of Healthcare before being promoted to her current role in April 2019.

Prior to joining H.C. Wainwright & Co., LLC, Aileen held several key positions in the healthcare and biotech sectors, including Senior Vice President of Investments at Health Care & Biotech and Senior Scientist in Product Development at Respira Therapeutics.

Her extensive background also includes academic roles such as Lecturer at the Royal College of Surgeons in Ireland and Postdoctoral Research Fellow at The University of Texas at Austin.

Aileen's career began with a focus on pharmacovigilance and drug development, having worked with the Irish Medicines Board and LEO Pharma.